The authors investigated the role of the endoplasmic reticulum (ER) chaperone AGR2 in modulating the unfolded protein response and the cancer cell secretome in gastroesophageal junction (GEJ) adenocarcinoma. They used shRNA-mediated silencing to reduce AGR2 expression in OE19 GEJ adenocarcinoma cells. To probe proteome-level changes in secreted proteins, conditioned media from control and AGR2-depleted cells were analyzed by high-throughput LC-MS/MS. Experiments were performed both under basal culture conditions and following pharmacologic induction of ER stress with tunicamycin.
Global proteomic screening of secreted proteins identified 75 proteins whose secretion was differentially regulated upon AGR2 depletion. Overall, AGR2 knockdown induced a widespread up-secretion phenotype across the secretome, indicating that loss of AGR2 alters protein trafficking and extracellular release. The LC-MS/MS approach enabled quantitative profiling of secreted factors, providing a dataset of proteins that change in abundance in the extracellular milieu when AGR2 is silenced.
Bioinformatic analysis of the differentially secreted proteins revealed pathway enrichments in several functional categories. Notable pathways included glycolysis, antigen processing and presentation, and extracellular matrix components. These enriched pathways suggest that AGR2 depletion reshapes multiple aspects of tumor cell biology that are represented in the secretome, including metabolic regulation, immune-related protein release, and extracellular matrix remodeling.
Among the proteins identified, the ER-resident chaperone GRP78 (also known as HSPA5 or BiP) emerged as a critical hub within the altered secretome. AGR2 knockdown was associated with a reduction of intracellular GRP78 expression. Concomitantly, UPR activation was reported to be compromised in AGR2-depleted cells, indicating that loss of AGR2 disrupts ER proteostasis mechanisms and the canonical adaptive stress signaling normally mediated by GRP78 and other UPR components.
Under conditions of pharmacologically induced ER stress with tunicamycin, AGR2-deficient OE19 cells exhibited a pronounced secretion of GRP78 into the extracellular space. The authors describe this as a massive release of GRP78 when AGR2 is absent, suggesting that AGR2 contributes to the intracellular retention of GRP78 under stress conditions. The extracellular appearance of GRP78 was a salient feature of the secretome remodeling linked to AGR2 depletion.
The shift in GRP78 localization and the compromised UPR in AGR2-silenced cells correlated with an increased sensitivity to tunicamycin-induced cell death. In other words, AGR2 depletion rendered GEJ adenocarcinoma cells less able to cope with ER stress and more prone to ER stress–mediated cytotoxicity. The data indicate a functional relationship in which AGR2 supports cell survival under proteotoxic stress by maintaining GRP78 proteostasis and ER retention.
Taken together, the findings identify AGR2 as a key regulator of GRP78 proteostasis and ER retention in OE19 gastroesophageal junction adenocarcinoma cells. By controlling the balance between intracellular retention and extracellular release of GRP78, AGR2 appears to sustain an adaptive ER stress response that may contribute to tumor cell survival. AGR2 depletion leads to broad secretome changes, enrichment of pathways relevant to metabolism, antigen presentation and extracellular matrix biology, and a specific vulnerability to tunicamycin-induced ER stress linked to GRP78 loss from the ER.
Notes on scope and reporting
All details above are drawn from the source abstract. Specific experimental parameters (for example, exact shRNA sequences, quantitative fold-changes for individual proteins, replicate numbers, or statistical metrics) were not reported in the abstract and therefore are not included here. The authors declare no competing interests in the published report.